403 results

Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder (opens ClinicalTrials.gov in a new tab)

Withdrawn Phase 2 0 participants Johns Hopkins University

Opioid Use Disorder

Group PACBT for Depression (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 30 participants University of California, Los Angeles

Depression - Major Depressive Disorder, Psilocybin, Cognitive Behavioral Therapy

Trial of Tirzepatide for the Treatment of Cannabis Use Disorder (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 100 participants National Institute on Drug Abuse (NIDA)

Cannabis Use Disorder

NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 83 participants M.D. Anderson Cancer Center

Psilocybin, Neuropathy

Clinical Trial of MDMA-Assisted Therapy for Military Service Members With Posttraumatic Stress Disorder (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 86 participants U.S. Army Medical Research and Development Command

PTSD, Post Traumatic Stress Disorder PTSD, Post Traumatic Stress Disorder

MDMA-Assisted Therapy for Stress Disorders in Healthcare Workers and First Responders (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 30 participants Nautilus Sanctuary

Post-Traumatic Stress Disorder, Adjustment Disorders

Psilocybin for Treatment of OCD-2 (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1/2 20 participants Francisco A Moreno

Obsessive - Compulsive Disorder

The Acute Effects of Psilocybin on Cognition, Memory, and Brain Function (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1/2 48 participants Manoj Doss

Healthy

Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2/3 300 participants COMPASS Pathways

PTSD - Post Traumatic Stress Disorder, PTSD, PTSD Symptoms, PTSD, Post Traumatic Stress Disorder

Pregnenolone for Cannabis Use Disorder and Depression (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1/2 20 participants University of Texas Southwestern Medical Center

Cannabis Use Disorder, Major Depressive Disorder (MDD)

Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 20 participants Roswell Park Cancer Institute

Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm

Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2/3 105 participants Johns Hopkins University

Alcohol Use Disorder (AUD), Withdrawal From Addictive Substance; Detoxification, Craving

Inhaled DMT for Major Depressive Disorder (opens ClinicalTrials.gov in a new tab)

Recruiting Phase 2 140 participants Universidade Federal do Rio Grande do Norte

MDD, Major Depressive Disorder (MDD), Major Depression, Suicidal Ideation

Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 76 participants University of Calgary

Post Traumatic Stress Disorder PTSD, Intimate Partner Violence (IPV)

Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1/2 50 participants Indiana University

Treatment Resistant Depression, Substance Use Disorders

Tirzepatide for the Treatment of Cannabis Use Disorder (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 6 participants Brigham and Women's Hospital

Cannabis Use Disorder

Psilocybin Efficacy With or Without Pimavanserin Pretreatment (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1/2 20 participants Johns Hopkins University

Mood (Psychological Function), Well Being, Mood, Healthy

MDMA-Assisted Massed Exposure Therapy for PTSD (opens ClinicalTrials.gov in a new tab)

Recruiting Phase 2 200 participants Emory University

Post Traumatic Stress Disorder

Study of Psilocybin Under Anesthesia Controlled by EEG (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 10 participants Stanford University

Major Depression

Mindfulness-based Psilocybin Therapy for PTSD (opens ClinicalTrials.gov in a new tab)

Recruiting Phase 2 30 participants Anthony P King

Post Traumatic Stress Disorder, Depression - Major Depressive Disorder

MDMA Therapy in Veterans With PTSD (opens ClinicalTrials.gov in a new tab)

Recruiting Phase 2 52 participants Sunstone Medical

Post Traumatic Stress Disorder

Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 36 participants Brigham and Women's Hospital

Alcohol Use Disorder

Cannabidiol Oil for Treatment-Resistant Major Depression (opens ClinicalTrials.gov in a new tab)

Recruiting Phase 1/2 120 participants Universidade do Sul de Santa Catarina

Major Depressive Disorder (MDD), Treatment-resistant Depression (TRD)

Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT) (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 120 participants Joshua Rosenblat

Borderline Personality Disorder (BPD), Treatment-Resistant Major Depressive Disorder, Treatment-resistant Bipolar Depression, Major Depressive Disorder (MDD)

The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 40 participants Yale University

Depression, Parkinson's Disease (PD)